What Misonix does

Misonix is a medical device company specializing in the design, development, manufacture, and marketing of ultrasonic surgical instruments used for precise bone cutting and soft tissue ablation. Founded in 1955 and headquartered in Farmingdale, United States, Misonix operates as a publicly traded entity (nasdaq:MSON) under the legal name Misonix LLC, with a workforce of 51–100 employees. The core technology converts ultrasonic energy into controlled cutting and ablation, intended to deliver precise bone cuts while minimizing thermal damage to surrounding tissue — a functional benefit relevant to spine, neurosurgical, and orthopedic procedures where conventional high-speed or powered instruments carry collateral-injury risk.

The company's product portfolio centers on three registered-trademark platforms: BoneScalpel (with Legacy and Access variants for varied surgical approaches), SonaStar (Elite and Legacy variants for soft tissue ablation and bone cutting), and SonicOne O.R., an integrated operating-room platform that combines bone cutting and soft tissue ablation capabilities. These devices are documented as FDA 510(k)-cleared, with regulatory clearance letters maintained as part of Bioventus Surgical's resource library. Sub-brands and product variants are distributed and sold through Bioventus Surgical's orthobiologics portfolio, suggesting a channel partnership or post-acquisition distribution relationship between Misonix LLC and Bioventus, though the precise ownership structure is not disclosed in the source data.

Misonix's business model combines capital-equipment sales (the ultrasonic consoles) with recurring consumable revenue (single-use tips and accessories) sold into hospitals and surgical specialist practices. Customers are primarily orthopedic surgeons, neurosurgeons, and other surgical specialists performing procedures that require precise bone cutting with controlled thermal margins. Pricing is not publicly disclosed. The company has pursued inorganic growth — most notably acquiring Solsys Medical in May 2019 for approximately $97 million, and earlier acquiring Fibra Sonics in 2001 — while also raising growth equity from healthcare-focused investors including 1315 Capital and SV Health Investors ($25 million in November 2017, followed by a $30 million round in January 2020).

Name

Misonix

Legal name

Misonix LLC

Website

https://misonix.com

Company type

Private

Founded year

1955

Headcount range

51–100 employees

Short description

Misonix designs, manufactures, and markets ultrasonic surgical devices (BoneScalpel, SonaStar, SonicOne O.R.) for precise bone cutting and soft tissue ablation. The company serves orthopedic surgeons, neurosurgeons, and other surgical specialists in hospital operating rooms, distributing products through Bioventus Surgical's orthobiologics channel.

Ownership category

akta.pro rank

Product category

Surgical Ultrasonic Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Ultrasonic surgical devices
• Bone cutting instruments
• Tissue ablation systems
• Surgical ultrasonic platforms
• Operating room equipment

Headquarters

HQ city

Farmingdale

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Misonix designs, develops, manufactures, and markets ultrasonic surgical devices used for precise bone cutting and soft tissue ablation in surgical procedures. Its core product portfolio includes the BoneScalpel, SonaStar, and SonicOne O.R. systems, which are sold and distributed through Bioventus Surgical's orthobiologics portfolio to surgical specialists and hospitals.

Product overview

Misonix offers a portfolio of ultrasonic surgical systems primarily consisting of the BoneScalpel, SonaStar, and SonicOne product lines. These devices utilize ultrasonic technology for precise bone cutting and soft tissue ablation in surgical procedures. The product portfolio includes multiple variants (Legacy, Elite, Access) that serve different surgical approaches and facility needs. BoneScalpel variants focus on bone cutting applications, SonaStar variants emphasize soft tissue ablation capabilities, while SonicOne O.R. represents an integrated operating room platform combining both capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• BoneScalpel: Registered trademark of Misonix LLC, a surgical ultrasonic device product line
• SonaStar
• SonicOne O.R.

Products and services

• BoneScalpel Ultrasonic surgical device designed for precise bone cutting with minimal thermal damage to surrounding tissues. Available in multiple variants including Legacy and Access versions. Used by orthopedic surgeons, neurosurgeons, and other surgical specialists performing procedures requiring precise bone cutting.
• SonaStar Ultrasonic surgical system for soft tissue ablation and bone cutting, offering precision in surgical procedures. Available in Elite and Legacy variants. Used by surgical specialists requiring both ablation and cutting capabilities.
• SonicOne O.R. Operating room ultrasonic surgical system combining bone cutting and soft tissue ablation capabilities in a single integrated platform. Used by hospitals and surgical centers for procedures requiring a versatile ultrasonic surgical solution.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Olympus:
• Ethicon (Johnson & Johnson): Ethicon's Harmonic ultrasonic devices compete with Misonix's soft-tissue ablation products (SonaStar) in general and specialty surgery. Ethicon brings global distribution, bundled energy-device contracts, and far larger R&D resources, making it a key incumbent competitor.
• Stryker: Stryker's SONOPET ultrasonic surgical aspirator competes directly with Misonix's SonaStar and BoneScalpel in spine and neurosurgery. Stryker's vastly larger sales force, capital, and broader surgical portfolio make it the most relevant scaled competitor in the same product category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/118182

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Misonix